Evidence map›Paper›PMID 35280817›Full record

ArticleFrontiers in oncology2022

Corrigendum: Chloroquine Inhibits Stemness of Esophageal Squamous Cell Carcinoma Cells Through Targeting CXCR4-STAT3 Pathway.

Dongli Yue, Daiqun Zhang, Xiaojuan Shi, Shasha Liu, Anqi Li, Dong Wang, Guohui Qin, Yu Ping, Yamin Qiao, Xinfeng Chen and 5 more

Open access · goldAbstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in oncology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 98% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

15 authors at 2 institutions in 1 country.

Dongli YueBiotherapy Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Daiqun ZhangBiotherapy Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Xiaojuan ShiBiotherapy Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Shasha LiuBiotherapy Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Anqi LiBiotherapy Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Dong WangBiotherapy Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Guohui QinBiotherapy Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Yu PingBiotherapy Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Yamin QiaoBiotherapy Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Xinfeng ChenBiotherapy Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Feng WangCancer Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Renyin ChenDepartment of Pathology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Song ZhaoDepartment of Thoracic Surgery, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Lidong WangHenan Key Laboratory for Esophageal Cancer Research and State Key Laboratory for Esophageal Cancer Prevention & Treatment of The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Yi ZhangBiotherapy Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
First Affiliated Hospital of Zhengzhou University · CNZhengzhou University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

[This corrects the article DOI: 10.3389/fonc.2020.00311.].

Indexed as

cancer stem cells (CSCs)chloroquine (CQ)CXCR4esophageal squamous cell carcinoma (ESCC)STAT3

Identifiers

PMID35280817
PMCPMC8908891
OpenAlexW4213450903

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.